Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics

Journal of Bacteriology

Volumn 178, Issue 15, 1996, Pages 4696-4703

  Billot Klein, Danièle ^a   Gutmann, Laurent ^a   Bryant, Duncan ^b   Bell, David ^b   Van Heijenoort, Jean ^c   Grewal, J ^d   Shlaes, David M ^a,d,e  

^a U de Rech Associee 1131 du Ctr N   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c GLAXOSMITHKLINE   (United Kingdom)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLYCOPEPTIDE; PEPTIDOGLYCAN; TEICOPLANIN; VANCOMYCIN;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; STAPHYLOCOCCUS HAEMOLYTICUS; STRUCTURE ACTIVITY RELATION;

STAPHYLOCOCCI; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 0029750226     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.178.15.4696-4703.1996     Document Type: Article

References (27)

1. Arthur, M., F. Depardieu, C. Molinas, et al. 1995. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 154:87-92.
2. Arthur, M., C. Molinas, F. Depardieu, and P. Courvalin. 1993. Characterization of Tn1546, a Ta3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175:117-127.
3. Beauregard, D. A., D. H. Williams, M. N. Gwynn, and D. J. C. Knowles. 1995. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemother. 39:781-785.
4. Billot-Klein, D., L. Gutmann, S. Sablé, E. Guittet, and J. van Heijenoort. 1994. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J. Bacteriol. 176:2398-2405.
5. Bugg, T. D. H., G. D. Wright, S. Dutka-Malen, M. Arthur, P. Courvalin, and C. T. Walsh. 1991. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistant proteins VanH and VanA. Biochemistry 30:10408-10415.
6. Daum, R. S., S. Gupta, R. Sabbagh, and W. M. Milewski. 1992. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect. Dis. 166:1066-1072.
7. de Jonge, B. L. M., Y. S. Chang, D. Gage, and A. Tomasz. 1992. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin-binding protein 2A. J. Biol. Chem. 267:11248-11254.
8. Glauner, B. 1988. Separation and quantification of muropeptides with high-performance liquid Chromatography. Anal. Biochem. 172:451-464.
9. Greenwood, D. 1988. Microbiological properties of teicoplanin. J. Antimicrob. Chemother. 21(Suppl. A):1-13.
10. Handwerger, S. 1944. Alterations in peptidoglycan precursors and vancomycin susceptibility in Tn917 insertion mutants of Enterococcus faecalis 221. Antimicrob. Agents Chemother. 38:473-475.
11. Herwaldt, L., L. Boyken, and M. Pfaller. 1991. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus hemolyticus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 10:1007-1012.
12. Kaatz, G. W., S. M. Seo, N. J. Dorman, and S. A. Lerner. 1990. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162:103-108.
13. Mackay, J. P., U. Gerhard, D. A. Beauregard, R. A. Maplestone, M. S. Westwell, M. S. Searle, and D. H. Williams. 1994. Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J. Am. Chem. Soc. 116:4581-4590.
14. Maidhof, H., B. Reinicke, P. Blümel, B. Berger-Bächi, and H. Labischinski. 1991. femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J. Bacteriol. 173:3507-3513.
15. Mainardi, J. L., D. M. Shlaes, R. V. Goering, J. H. Shlaes, J. F. Acar, and F. W. Goldstein. 1995. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J. Infect. Dis. 171:1646-1650.
16. +-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:166-172.
17. Noble, W. C., Z. Virani, and R. G. A. Gee. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198.
18. O'Hare, M. D., and P. E. Reynolds. 1992. Novel membrane proteins present in teicoplanin-resistant vancomycin sensitive coagulase negative Staphylococcus spp. J. Antimicrob. Chemother. 30:753-768.
19. Recsei, P. A., A. D. Gruss, and R. P. Novick. 1987. Cloning, sequence and expression of the lysostaphin gene from Staphylococcus simulans. Proc. Natl. Acad. Sci. USA 84:1127-1131.
20. Schleifer, K. H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.
21. Schwalbe, R. S., J. T. Stapleton, and P. H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase negative staphylococci. N. Engl. J. Med. 36:927-931.
22. Shlaes, D. M., and L. Herwaldt. Unpublished observations.
23. Shlaes, D. M., and J. H. Shlaes. 1995. Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin. Clin. Infect. Dis. 20:1071-1073.
24. Shlaes, D. M., J. H. Shlaes, S. Vincent, L. Etter, P. D. Fey, and R. V. Goering. 1993. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob. Agents Chemother. 37:2432-2437.
25. Somner, E. A., and P. E. Reynolds. 1990. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob. Agents Chemother. 34:413-419.
26. Sugai, M., H. Komatsuzawa, T. Akiyama, Y.-M. Hong, T. Oshida, Y. Miyake, T. Yamaguchi, and H. Suginaka. 1995. Identification of endo-β-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus. J. Bacteriol. 177:1491-1496.
27. Verina, P. R., N. E. Allen, J. N. Hobbs, Jr., J. A. Johnson, J. G. Morris, Jr., and R. S. Schwalbe. 1994. Characterization of vancomycin resistance in Staphylococcus haemolyticus, abstr. C47, p. 76. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.